Modified endoscopic retrograde appendicitis therapy vs. laparoscopic appendectomy for uncomplicated acute appendicitis in children

医学 阑尾炎 腹腔镜检查 急性阑尾炎 普通外科
作者
Anding Zhang,Yalong Zhang,Na Fan,Yaxing Hui,Ying Zhou,Lingchao Zeng,Chunhui Wang,Lei Shang,Ke Qi,Xiaobao He,Lin Yan,Xun Jiang
出处
期刊:Digestive Endoscopy [Wiley]
卷期号:36 (9): 1012-1020 被引量:4
标识
DOI:10.1111/den.14753
摘要

Objectives Modified endoscopic retrograde appendicitis therapy (mERAT) has been proposed as an alternative to laparoscopic appendectomy for the treatment of appendicitis. However, data from children in large samples are lacking. The aim of this article is to evaluate the efficacy between mERAT and laparoscopic appendectomy (LA) in children with uncomplicated appendicitis. Method We retrospectively analyzed 594 patients with suspected uncomplicated appendicitis from October 2018 to May 2021. A pool of 294 consecutive patients who met the inclusion criteria were ultimately enrolled in this study (228 and 66 patients in mERAT and LA, respectively). Given the differences in baseline clinical data (gender, age), the regression equation including differences in clinical baseline, grouping factor, and white blood cell count was established to address the influence of potential confounding factors. Result The initial success rate of mERAT management was 96.9%, and the recurrence rate was 6.9% in the mERAT group and 1.7% in the LA group within 1 year, which was no significant difference. But the mERAT group had a lower rate of adverse events. Finally, those results indicated that the treatment modalities, LA or mERAT, had no significant effect on initial success rate ( P = 0.99) or recurrence rate ( P = 0.17) within 1 year, but a significant effect on the adverse events rate during hospitalization ( P = 0.01) in the multivariate regression analysis. Conclusion Among children with uncomplicated appendicitis, an initial mERAT management strategy had a success rate of 96.9%, which was similar to the LA group at 1 year. This follow‐up supports the feasibility of mERAT alone as an alternative to surgery for uncomplicated appendicitis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
艺术家完成签到 ,获得积分10
刚刚
朴素代芙完成签到,获得积分10
1秒前
贪玩的万仇完成签到,获得积分10
3秒前
含蓄的赛君完成签到 ,获得积分10
3秒前
忧郁难胜完成签到,获得积分10
3秒前
wakaka123完成签到 ,获得积分10
3秒前
快乐达不刘完成签到,获得积分10
3秒前
jinboyuan应助GFY采纳,获得10
4秒前
在水一方应助乖猫要努力采纳,获得10
4秒前
笨笨凡松完成签到,获得积分10
5秒前
kong完成签到,获得积分10
5秒前
自然可乐完成签到,获得积分10
6秒前
6秒前
ZHDNCG完成签到,获得积分10
6秒前
研友_ZGXj48完成签到,获得积分20
7秒前
量子星尘发布了新的文献求助10
7秒前
玄学大哥完成签到,获得积分10
8秒前
司徒诗蕾发布了新的文献求助10
8秒前
Siso发布了新的文献求助10
9秒前
10秒前
爱猫的纭发布了新的文献求助10
10秒前
今者当歌应助蔬菜狗狗采纳,获得10
11秒前
Sera完成签到,获得积分10
11秒前
縤雨完成签到 ,获得积分10
11秒前
闾丘广缘完成签到,获得积分10
11秒前
十一完成签到,获得积分10
12秒前
零度寂寞3166完成签到,获得积分10
12秒前
Bink完成签到 ,获得积分10
13秒前
夏天就是桃子味完成签到,获得积分10
14秒前
15秒前
cgs完成签到,获得积分20
15秒前
11完成签到,获得积分10
15秒前
登山人完成签到,获得积分10
16秒前
阿拉哈哈笑完成签到,获得积分10
16秒前
罗大大完成签到 ,获得积分10
16秒前
狼牧羊城完成签到,获得积分10
16秒前
FCH2023完成签到,获得积分10
17秒前
颖儿完成签到,获得积分10
17秒前
机智的皮皮虾完成签到,获得积分10
18秒前
科研通AI2S应助爱猫的纭采纳,获得10
18秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3957219
求助须知:如何正确求助?哪些是违规求助? 3503261
关于积分的说明 11112080
捐赠科研通 3234372
什么是DOI,文献DOI怎么找? 1787895
邀请新用户注册赠送积分活动 870817
科研通“疑难数据库(出版商)”最低求助积分说明 802330